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Hepatic cholesterol(ester) uptake from serum coupled
to intracellular processing and biliary excretion are im-
portant features in the removal of excess cholesterol
from the body. ATP-binding cassette (ABC) transporters
play an important role in hepatic cholesterol transport.
The liver consists of different cell types, and ABC trans-
porters may exert different physiological functions de-
pendent on the individual cell type. Therefore, in the
current study, using real time PCR we compared the
mRNA expression of ABC transporters and genes in-
volved in the regulation of cholesterol metabolism in
liver parenchymal, endothelial, and Kupffer cells. It ap-
pears that liver parenchymal cells contain high expres-
sion levels compared with endothelial and Kupffer cells
of scavenger receptor class BI (3-fold), peroxisome pro-
liferator-activated receptor (PPAR) and PPAR (8–20-
fold), cholesterol 7-hydroxylase A1 (>100-fold), and
ABCG5/G8 (5-fold). Liver endothelial cells show a high
expression of cholesterol 27-hydroxylase, liver X recep-
tor (LXR), PPAR, and ABCG1, suggesting a novel spe-
cific role for these genes in endothelial cells. In Kupffer
cells, the expression level of LXR, ABCA1, and in par-
ticular ABCG1 is high, leading to an ABCG1 mRNA
expression level that is 70-fold higher than in paren-
chymal cells. It can be calculated that 51% of the total
liver ABCG1 expression resides in Kupffer cells and
24% in endothelial cells, suggesting an intrahepatic-
specific role for ABCG1 in Kupffer and endothelial
cells. Because of a specific stimulation of ABCG1 in pa-
renchymal cells by a high cholesterol diet, the contribu-
tion of parenchymal cells to the total liver increased
from 25 to 60%. Our data indicate that for studies of the
role of ABC transporters and their regulation in liver,
their cellular localization should be taken into account,
allowing proper interpretation of metabolic changes,
which are directly related to their (intra)cellular ex-
pression level.
Transport of cholesterol through the body is an important
process in the maintenance of total body cholesterol homeosta-
sis. One specific component is the transport of excessive cho-
lesterol from the periphery to the liver by the high density
lipoprotein (HDL).1 This process is called reverse cholesterol
transport and consists of three different stages: the efflux of
peripheral cellular cholesterol to HDL, the transport of choles-
terol esters through the blood to the liver, and the uptake of
cholesterol esters by the liver (1). Cholesterol esters are taken
up into the liver through selective uptake by the HDL receptor,
scavenger receptor class BI (SR-BI) (2), where they are primar-
ily (50%) catabolized to bile acids, through conversion by
cholesterol 7-hydroxylase (CYP7A1) and sterol 27-hydroxy-
lase (CYP27) (3) for biliary excretion via the bile salt export
protein (4). A second major catabolic route (40%) is the direct
efflux of cholesterol from the liver into the bile via the ABC
half-transporters ABCG5 and ABCG8, which together function
as a biliary sterol efflux regulator (5). Additionally, cholesterol
also effluxes from the liver to produce very low density lipopro-
teins, which are converted to remnants that function as pre-
cursors for low density lipoproteins. Native HDL might also be
formed by the ABC transporter A1 (ABCA1)-mediated choles-
terol efflux (6). Recently, another member of the ABC trans-
porter family, ABCG1, has been proposed to play a role in the
intracellular trafficking and efflux of cholesterol (7). However,
the exact role of ABCG1 in the liver, especially in relation to
ABCG5 and ABCG8, remains to be clarified.
The identification of SR-BI and novel members of the ABC
transporter family, including ABCA1, ABCG1, ABCG5, and
ABCG8, has allowed the molecular characterization of the in-
dividual transporters responsible for the intracellular traffick-
ing and excretion of cholesterol (derivatives). In the liver, it has
been shown that SR-BI is responsible primarily for the selec-
tive uptake of cholesterol esters from HDL (8), whereas
ABCG5/G8 and ABCG1, and ABCA1, are proposed mediators of
efflux to the bile and to HDL, respectively (6, 9). However, the
liver is a complex tissue and contains, in addition to the paren-
chymal cells, which are localized around the bile canaliculi,
endothelial cells, and tissue macrophages (Kupffer cells). To
assess the individual function of the ABC transporters and
their regulation by nuclear hormone receptors it is therefore
essential to establish their cellular localization in the liver.
Here we report that key mediators in liver cholesterol home-
ostasis, in particular PPAR, PPAR, and ABCG1, are ex-
pressed differentially in specific cell types of the rat liver. Our
data stress that it is necessary to focus on the regulation of
genes involved in cholesterol homeostasis in the different cell
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types of the liver to get molecular insight in their mechanism of
regulation and the consequences for liver cholesterol transport.
EXPERIMENTAL PROCEDURES
Animals—In the study, three male Wistar WU rats (200–250 g) were
fed a chow diet containing 4.3% (w/w) fat and no cholesterol, and three
rats were fed a high cholesterol diet containing 2% (w/w) cholesterol, 5%
olive oil (w/w), and 0.5% (w/w) cholic acid for 2 weeks. Rats were
anesthetized and the vena porta was cannulated. Subsequently, the
liver was perfused for 10 min with oxygenated Hanks’ buffer, pH 7.4,
containing HEPES (1.6 g/liter). The perfusion was continued for 10 min
with Hanks’/HEPES buffer containing 0.05% (w/v) collagenase (type IV,
Sigma) and 1 mM CaCl2. Parenchymal cells were isolated after mincing
the liver in Hanks’ buffer containing 0.3% bovine serum albumin,
filtering through nylon gauze and centrifugation for three times 10 min
at 50  g. The pellets consisted of pure (99%) parenchymal cells as
judged by light microscopy. The supernatants were centrifuged for 10
min at 500  g to harvest the non-parenchymal cells. By means of
centrifugal elutriation the endothelial cells and Kupffer cells were
separated (10). The purity of each cell fraction (95% for both) was
checked by light microscopy, after staining for peroxidase activity with
3,3-diaminobenzidine (Sigma).
Analysis of Gene Expression by Real Time Quantitative PCR—Total
RNA was isolated from rat liver parenchymal, endothelial, and Kupffer
cells using TriZol reagent (Invitrogen) according to the manufacturer’s
instructions. Purified RNA was DNase treated (DNase I, 10 units/g of
total RNA) and reverse transcribed (RevertAid M-MuLV reverse tran-
scriptase) according to the protocols supplied by the manufacturer.
Quantitative gene expression analysis was performed on an ABI
PRISM 7700 machine (Applied Biosystems, Foster City, CA) using
SYBR Green technology. PCR primers (Table I) were designed using
Primer Express 1.7 software with the manufacturer’s default settings
(Applied Biosystems) and validated for identical efficiencies (slope 
3.3 for a plot of the threshold cycle number (Ct) versus log ng cDNA).
In 96-wells optical plates, 12.5 l of SYBR Green master mix was added
to 12.5 l of cDNA (corresponding to 50 ng of total RNA input) and 300
nM forward and reverse primers in water. Plates were heated for 2 min
at 50 °C and 10 min at 95 °C. Subsequently 40 PCR cycles consisting of
15 s at 95 °C and 60 s at 60 °C were applied. At the end of the run,
samples were heated to 95 °C with a ramp time of 20 min to construct
dissociation curves to check that single PCR products were obtained.
The absence of genomic DNA contamination in the RNA preparations
was confirmed by using total RNA samples that had not been subjected
to reverse transcription. Hypoxanthine-guanine phosphoribosyltrans-
ferase (HPRT) was used as the standard housekeeping gene. Ratios of
target gene and HPRT expression levels (relative gene expression num-
bers) were calculated by subtracting the Ct of the target gene from the
Ct of HPRT and raising 2 to the power of this difference. Ct values are
defined as the number of PCR cycles at which the fluorescent signal
during the PCR reaches a fixed threshold. Target gene mRNA expres-
sions are thus expressed relative to HPRT expression.
Data Analysis—The significance of differences in relative gene ex-
pression numbers among the different liver cell types, from three dif-
ferent cell isolations, measured by real time quantitative PCR was
calculated using a two-tailed Student’s t test on the differences in Ct
(Ct(HPRT)  Ct(target gene)). Probability values less than 0.05 were consid-
ered significant.
RESULTS
The last step in reverse cholesterol transport is the hepatic
uptake and cellular processing of cholesterol esters from HDL
by SR-BI (1). The mRNA expression of SR-BI in the different
cell types of the liver was investigated with quantitative real
time PCR to determine which cell type is mainly expressing
SR-BI. A significantly higher SR-BI expression was observed in
parenchymal cells compared with endothelial (p  0.05) and
Kupffer cells (p  0.01) (Fig. 1).
In the liver, cholesterol is used for bile acid synthesis. There-
fore, the mRNA expression patterns of two key enzymes in bile
acid synthesis, CYP7A1 and CYP27, in the different hepatic
cell types were examined. A relatively high level of CYP7A1
expression was observed in parenchymal cells, which was more
than 200-fold (p  0.001) higher than the expression levels
found in endothelial and Kupffer cells (Fig. 2a). Accordingly,
CYP27 expression (Fig. 2b) was observed in parenchymal cells
and also in endothelial cells.
Because a second route of cholesterol disposal from the liver
is through direct excretion of cholesterol into the bile via the
half-transporters ABCG5 and ABCG8, we investigated
whether the expression of ABCG5/8 is also higher in parenchy-
mal cells than in non-parenchymal cells. Fig. 3 clearly indicates
that ABCG5 (a) and ABCG8 (b) expression was indeed 5–10-
fold higher in parenchymal cells compared with endothelial
and Kupffer cells.
In the liver, ABCA1 was recently suggested to be involved in
the efflux of cholesterol for production of HDL (6). Although no
conclusive evidence has been shown, in the liver ABCG1, like
ABCG5/G8, is proposed to play a role in biliary efflux (11). In
macrophages, ABCA1 and ABCG1 expression is induced in
response to cholesterol loading, and both proteins are poten-
tially involved in cholesterol efflux to apoA-I (12). Because both
ABCA1 and ABCG1 are implicated in the same physiological
functions, we determined whether both genes also have a com-
parable expression distribution profile over the different cell
types of the liver. Contrary to the assumption, ABCA1 was
expressed mainly in parenchymal and Kupffer cells (Fig. 4a),
whereas ABCG1 was expressed 76-fold (p  0.001) and 27-fold
(p  0.01) higher in Kupffer and endothelial cells than in
parenchymal cells, respectively (Fig. 4b). In contrast to ABCA1,
ABCG1 is thus mainly expressed in non-parenchymal cells,
which suggests a limited role of ABCG1 in the excretion of
cholesterol directly into the bile under the standard feeding
conditions. In addition, ABCG1 expression was analyzed in the
different hepatic cells isolated from rats on a high cholesterol
diet. Interestingly, hepatic parenchymal cell ABCG1 expres-
sion increased 4-fold (p  0.05) in response to a high choles-
terol diet, whereas no significant effect on endothelial and
TABLE I
Primers for quantitative real time PCR analysis
Gene GenBankaccession Forward primer Reverse primer Amplicon size
ABCA1a ATCTCATAGTATGGAAGAATGTGAAGCT CGTACAACTATTGTATAACCATCTCCAAA 132
ABCG1 NM053502 AGGTCTCAGCCTTCTAAAGTTCCTC TCTCTCGAAGTGAATGAAATTTATCG 85
ABCG5 NM053754 CGCAGGAACCGCATTGTAA TGTCGAAGTGGTGGAAGAGCT 67
ABCG8 NM130414 GATGCTGGCTATCATAGGGAGC TCTCTGCCTGTGATAACGTCGA 69
CYP27 M38566 GTGTCCCGGGATCCCAGTGT CTTCCTCAGCCATCGGTGA 66
CYP7A1 NM012942 CTGTCATACCACAAAGTCTTATGTCA ATGCTTCTGTGTCCAAATGCC 75
HPRT X62085 TTGCTCGAGATGTCATGAAGGA AGCAGGTCAGCAAAGAACTTATAG 91
LXR NM031627 TCAGCATCTTCTCTGCAGACCGG TCATTAGCATCCGTGGGAACA 144
LXR NM031626 AAGCTGGTGAGCCTGCGC CGGCAGCTTCTTGTCCTG 81
PPAR NM013196 TGAACAAAGACGGGATG TCAAACTTGGGTTCCATGAT 106
PPAR NM013124 CATGCTTGTGAAGGATGCAAG TTCTGAAACCGACAGTACTGACAT 131
PPAR NM012141 GAGGGGTGCAAGGGCTTCTT CACTTGTTGCGGTTCTTCTTCTG 97
SR-BI U76205 GTTGGTCACCATGGGCCA CGTAGCCCCACAGGATCTCA 65
a Primer sequences based on an alignment of human (NM005502) and murine (XM109397) ABCA1.
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Kupffer cell ABCG1 expression was observed (Fig. 5). Although
ABCG1 levels were significantly increased in parenchymal
cells in response to a high cholesterol diet, ABCG1 expression
levels were still, respectively, 10- and 12-fold higher in endo-
thelial and Kupffer cells compared with parenchymal cells.
Analysis of LXR expression in the different cell types was
performed to investigate a potential relation with expression
patterns of the ABC transporters. LXR had a distribution
pattern comparable to that found for ABCA1, with a relatively
high expression in parenchymal (p  0.01) and Kupffer cells
compared with endothelial cells (Fig. 6a). A significantly higher
expression of LXR was found in endothelial liver cells com-
pared with parenchymal (p 0.05) and Kupffer cells (p 0.05),
respectively (Fig. 6b), which suggests that LXR may be a more
important mediator in endothelial cells.
It has been shown that PPAR activators are able to regulate
LXR expression, and thereby indirectly influence ABCA1
mRNA levels (13), and that ligands for PPAR directly regulate
the expression of ABCA1 via an unknown mechanism (14).
Therefore, we also investigated the PPAR gene expression in
the different cell types. Fig. 7a clearly indicates that PPAR
expression is found mostly in parenchymal cells, with an 82-
and 23-fold higher expression (p 0.001 in both cases) in these
cells than in endothelial cells and Kupffer cells, respectively.
The PPAR distribution pattern is comparable with that found
for PPAR (Fig. 7b), suggesting a major function of these genes
in parenchymal cells. PPAR mRNA levels were almost equal
in the different cells, although endothelial cell PPAR expres-
FIG. 1. Relative SR-BI mRNA expression levels as determined
by real time quantitative PCR in liver parenchymal (PC), endo-
thelial (EC), and Kupffer (KC) cells from rats on a chow diet.
Values are expressed relative to HPRT expression (mean  S.E.). p 
0.05 (*) and p  0.01 (**) compared with PC expression (t test, as
described under “Experimental Procedures”).
FIG. 2. Relative CYP7A1 (a) and CYP27 (b) mRNA expression
levels as determined by real time quantitative PCR in liver
parenchymal (PC), endothelial (EC), and Kupffer (KC) cells from
rats on a chow diet. Values are expressed relative to HPRT expres-
sion (mean  S.E.). p  0.01 (**) and p  0.001 (***) compared with PC
expression (t test, as described under “Experimental Procedures”).
FIG. 3. Relative ABCG5 (a) and ABCG8 (b) mRNA expression
levels as determined by real time quantitative PCR in liver
parenchymal (PC), endothelial (EC), and Kupffer (KC) cells from
rats on a chow diet. Values are expressed relative to HPRT expres-
sion (mean  S.E.). p  0.05 (*) and p  0.001 (***) compared with PC
expression (t test, as described under “Experimental Procedures”).
FIG. 4. Relative ABCA1 (a) and ABCG1 (b) mRNA expression
levels as determined by real time quantitative PCR in liver
parenchymal (PC), endothelial (EC), and Kupffer (KC) cells from
rats on a chow diet. Values are expressed relative to HPRT expres-
sion (mean  S.E.). p  0.05 (*) and p  0.001 (***) compared with PC
expression (t test, as described under “Experimental Procedures”).
FIG. 5. Effect of a high cholesterol diet on the relative ABCG1
mRNA expression levels as determined by real time quantita-
tive PCR in liver parenchymal (PC), endothelial (EC), and
Kupffer (KC) cells. Values from rats on a chow diet (black bars) and
on a high cholesterol diet (hatched bars) are expressed relative to HPRT
expression (mean  S.E.). *, p  0.05 compared with the ABCG1
expression on a chow diet (t test, as described under “Experimental
Procedures”).
FIG. 6. Relative LXR (a) and LXR (b) mRNA expression lev-
els as determined by real time quantitative PCR in liver paren-
chymal (PC), endothelial (EC), and Kupffer (KC) cells from rats
on a chow diet. Values are expressed relative to HPRT expression
(mean  S.E.). **, p  0.01 compared with PC expression; #, p  0.05
compared with EC expression (t test, as described under “Experimental
Procedures”).
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sion was somewhat higher as compared with parenchymal and
Kupffer cells (Fig. 7c). These data indicate that within the
various liver cell types PPAR will have a more general
function.
DISCUSSION
Hepatic cholesterol uptake from serum coupled with intra-
cellular processing and bile excretion are important features in
the last step of reverse cholesterol transport. It has been shown
that disruption of cholesterol homeostasis plays an essential
role in the pathology of many diseases such as cholestasis (15)
and atherosclerosis (16).
In the liver, SR-BI plays a crucial role in the selective uptake
of cholesterol esters from HDL (2). Additionally, studies on
ABC transporters suggested that hepatic ABCA1 is involved in
HDL production (6), whereas ABCG5/G8 and ABCG1 were
indicated to mediate biliary efflux of cholesterol from the liver
(7, 9). Repa et al. (17) showed that treatment of mice with
synthetic ligands of LXR markedly increased liver ABCG5/G8
expression. In vitro observations by Malerod et al. (18) also
indicate that LXR is able to regulate hepatic SR-BI expression
through a direct interaction with a newly discovered LXR/
retinoid X receptor response element in the SR-BI promoter. It
is however still unclear how hepatic ABCA1 and ABCG1 ex-
pression is regulated and what the precise consequence of their
regulation is on hepatic cholesterol levels and transport.
The liver consists of several different cell types, including
parenchymal, endothelial, and Kupffer cells. It is therefore
important to study the expression levels of SR-BI and the ABC
transporters in the individual hepatic cell types to get a more
detailed view of their specific functions and regulatory mecha-
nisms in the liver.
Earlier studies performed by Pieters et al. (19) showed that
uptake of HDL cholesterol esters into liver parenchymal cells is
efficiently coupled to a rapid synthesis of bile acids. Accord-
ingly, Fluiter et al. (20) observed that the receptor responsible
for the selective uptake of cholesterol esters into the liver,
SR-BI, has a relatively high expression in parenchymal cells
compared with endothelial and Kupffer cells. These combined
observations stressed an important role for parenchymal cells
in the last step of the reverse cholesterol transport process.
In the current study, using real time quantitative PCR, we
investigated the mRNA expression of genes involved in hepatic
cholesterol transport and metabolism in liver parenchymal,
endothelial, and Kupffer cells. Real time PCR is a highly sen-
sitive method to quantify mRNA expression levels in vitro and
in vivo. mRNA levels have been shown to correlate strongly
with protein expression levels, indicating that a substantial
portion of changes in protein levels is a consequence of altered
mRNA levels rather than post-transcriptional modifications
(21).
Importantly, Wellington et al. (22) showed a high concord-
ance of ABCA1 mRNA and protein levels in the liver. Addition-
ally, we observed in the present study the highest SR-BI mRNA
expression in the parenchymal cells compared with endothelial
and Kupffer cells, which is in accordance with the high Western
blot protein expression data for SR-BI as reported by Fluiter et
al. (20). We thus suggest that our quantitative mRNA data for
the various cell types are indicative for the activity of the
particular genes of interest and their metabolic function. For
SR-BI, the mRNA and protein expression data in parenchymal
cells are consistent with our data that the parenchymal cho-
lesterol ester uptake is reduced dramatically in SR-BI deficient
mice as compared with non-transgenic littermates.2 CYP7A1
and CYP27 are the key enzymes in classical and alternative
bile acid synthesis pathways (23). The relatively high expres-
sion of these two bile acid synthesis enzymes observed in pa-
renchymal cells is in agreement with the data provided by
Pieters et al. (19), as it was shown that uptake of HDL choles-
terol esters by the parenchymal cells is coupled efficiently to
bile acid synthesis. Interestingly, an equally high expression of
CYP27 compared with parenchymal cells was observed in liver
endothelial cells. In agreement, Reiss et al. (24) have detected
the same high levels of CYP27 activity in cultured vascular
endothelial cells. The observed difference between the CYP7A1
and CYP27 expression patterns suggests differential functions
for these bile acid synthesizing enzymes. Interestingly, Babiker
et al. (25) suggested that CYP27-mediated elimination of cho-
lesterol from macrophages and endothelial cells may be an
alternative or complement to HDL-mediated reverse choles-
terol transport under low HDL conditions. They observed a
high secretion of 3-hydroxycholestenoic acid, an intermediate
of the CYP27-mediated alternative bile acid formation path-
way, from endothelial cells and macrophages to albumin con-
taining medium.
Efflux of hepatic cholesterol to the serum compartment by
ABCA1 for the production of native HDL is a second important
route in maintaining cholesterol homeostasis (6). An equally
high relative expression of ABCA1 was observed in parenchy-
mal and Kupffer cells, whereas a 4-fold lower expression of
ABCA1 was seen in liver endothelial cells. In macrophages,
ABCA1 is a critical regulator of the specific ATP-dependent
cholesterol efflux to apoA-I, leading to an inhibition of foam cell
formation (26). Kupffer cells are liver macrophages, which play
an important role in the uptake of (modified) lipoproteins (19,
27). The high uptake and an accordingly high efflux of choles-
terol from Kupffer cells might be the metabolic mechanism for
the relatively high ABCA1 expression level observed in these
cells. Haghpassand et al. (28) and Van Eck et al. (29) have
shown that monocyte/macrophage ABCA1 only minimally con-
tributes to the overall plasma HDL levels. The observed high
expression levels of ABCA1 in parenchymal cells, combined
2 J. K. Kruijt and Th. J. C. van Berkel, unpublished data.
FIG. 7. Relative PPAR (a), PPAR (b), and PPAR (c) mRNA
expression levels as determined by real time quantitative PCR
in liver parenchymal (PC), endothelial (EC), and Kupffer (KC)
cells from rats on a chow diet. Values are expressed relative to
HPRT expression (mean  S.E.). p  0.05 (*), p  0.01 (**), and p 
0.001 (***) compared with PC expression; #, p 0.05 compared with EC
expression (t test, as described under “Experimental Procedures”).
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with the observation that ABCA1 functions on the basolateral
surface of hepatocytes (30), suggest that the liver does contrib-
ute to HDL production by the efflux of cholesterol from paren-
chymal cells via ABCA1.
A third catabolic route for hepatic cholesterol is the direct
excretion into the bile, which accounts for 40% of the total
liver catabolism. Recently, two members of the ABC transport-
ers, ABCG5 and ABCG8, have been shown to participate coor-
dinately in the hepatic sterol secretion into bile (31). Mutations
in either ABCG5 or ABCG8 are sufficient to cause sitosterol-
emia, a disorder that is characterized by elevated plasma levels
of sterols (32). Because parenchymal cells are responsible for
bile acid formation, a relatively high expression of the biliary
transporters such as ABCG5/G8 in these cells compared with
endothelial and Kupffer cells is consistent with their suggested
function. The expression pattern of ABCG5 resembled ABCG8,
which is in agreement with the statements that these trans-
porters operate as heterodimers to regulate biliary cholesterol
efflux (9, 33).
Interestingly, a novel member of the ABC transporter family,
ABCG1, has also been proposed to have a function in the
intracellular trafficking and biliary efflux of cholesterol in the
liver (11). Contrary to the expectations, ABCG1 expression was
observed mainly in non-parenchymal cells of the rat liver. A
76-fold and 27-fold higher ABCG1 expression was observed in
Kupffer and endothelial cells than in parenchymal cell under
standard feeding conditions. Although Kupffer and endothelial
cells only contribute 2.5 and 3.3% to the total liver protein, they
do contain 51 and 24% of total liver ABCG1 expression, respec-
tively. Such a high specific ABCG1 expression in Kupffer cells
was not expected, although ABCG1 has also been proposed to
play a role in the cholesterol efflux from peripheral macro-
phages (7). Importantly, after putting rats on a high cholesterol
diet for 2 weeks, ABCG1 expression increased 4-fold in paren-
chymal cells, whereas no significant change in ABCG1 expres-
sion in endothelial and Kupffer cells was observed. The absence
of a similar induction of ABCG1 in endothelial and Kupffer
cells in response to diet feeding may well be caused by an
already maximal activity of ABCG1 in these cells even on a
chow diet. Also, the differences in expression and intracellular
localization of direct activators (e.g. LXR) and repressors (e.g.
ZNF202) of ABCG1 might contribute to the difference in its
transcriptional regulation between different cell types as ear-
lier mentioned by Schmitz and Langmann (11). Although en-
dothelial and Kupffer cell ABCG1 expressions were still 10-
and 12-fold higher than that in parenchymal cells, the relative
contribution of ABCG1 in the parenchymal cells to total liver
increased from 25 to 60%. This suggests that under high cho-
lesterol conditions ABCG1 might indeed contribute to the
transport of cholesterol in the parenchymal cells.
Recent pharmacological interest is focused upon the regula-
tion of SR-BI and the ABC transporters by newly discovered
nuclear hormone receptors, the LXRs and PPARs, respectively
(34, 35). Therefore, we also studied their cellular localization in
the different cell types of the liver.
Two different types of the LXR have been discovered so far,
LXR and LXR. A relatively high expression of LXR was
observed in parenchymal cells. In the liver, LXR plays an
essential role in the regulation of CYP7A1 and thus the forma-
tion of bile acids (36). CYP7A1 was found almost exclusively in
the parenchymal cells, which coincides with the high expres-
sion of LXR in these cells. Contrarily, equally high LXR
expression levels were observed in Kupffer cells, where
CYP7A1 expression was almost absent. In macrophages, how-
ever, LXR plays a crucial role in the regulation of lipid efflux
via ABCA1 (37). Kupffer cells also contain high expression
levels of ABCA1, which is consistent with a role for LXR in the
regulation of ABCA1 in these cells. Among the different cell
types of the liver, LXR was ubiquitously expressed, with a
somewhat higher expression in endothelial cells versus paren-
chymal and Kupffer cells. The expression distribution of LXR
thus does not resemble that found for LXR, which suggests
that in the liver, LXR may have a function different from that
of LXR.
In the liver, PPAR is suggested to play a role in the forma-
tion of bile acids because it is able to bind a PPAR response
element in the sterol 12-hydroxylase promoter, leading to
increased levels of cholic acid (38). This might explain the
extremely high expression of PPAR found in parenchymal
cells compared with endothelial and Kupffer cells. The high
expression of PPAR observed in parenchymal cells suggests
that PPAR, like PPAR, also has a major function in these
cells. Contrarily, PPAR is expressed ubiquitously among the
different cell types of the liver, suggesting a more general
function for PPAR in all cell types of the liver.
In conclusion, we have provided data that several ABC trans-
porters and nuclear hormone receptors involved in liver cho-
lesterol homeostasis are expressed differentially in the specific
cell types of the liver. To study their intracellular transport
function inside the liver it appears to be essential to take into
account their cellular localization, as especially evident for
ABCG1. This appears specifically true for studies on the regu-
lation of the transporters by nuclear receptors because meta-
bolic changes are coupled directly to the specific (intra)cellular
expression level of the cholesterol transporters.
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